Target intelligence / Profile preview

28S ribosomal RNA (28S rRNA) (28S rRNA)

Target
28S rRNA
Molecular classification
Other, Ribonucleoprotein
01

Overview

The 28S ribosomal RNA (28S rRNA) is a fundamental structural and catalytic component of the eukaryotic 60S ribosomal subunit, essential for the process of translation and peptide bond formation (Endo et al., 1988). It is the primary molecular target for mistletoe lectin A-chain (ML-A), a Type II ribosome-inactivating protein (RIP) derived from the Viscum album plant (Büssing, 2000). ML-A exhibits potent RNA N-glycosidase activity, specifically targeting the highly conserved sarcin/ricin loop (SRL) of the 28S rRNA and removing a single adenine residue at position A4324 (UniProt P06750). This site-specific depurination prevents the binding of elongation factors EF-1 and EF-2, leading to an irreversible halt in protein synthesis and the induction of the ribotoxic stress response. In clinical oncology, mistletoe extracts containing these lectins, such as Iscador and Helixor, are utilized as complementary therapies to induce apoptosis in malignant cells and stimulate the host immune system (Kienle & Kiene, 2010). The interaction between ML-A and the ribosome triggers multiple signaling cascades, including the activation of JNK and p38 mitogen-activated protein kinases, which further promote programmed cell death. While the ribosome is a ubiquitous target, the therapeutic window of mistletoe lectins is managed through specific dosing and the cell-binding properties of the associated B-chain, which facilitates entry into target cells.

Other names
28S rRNALarge ribosomal subunitSarcin/ricin loopSRL60S ribosomal subunitRibosome
02

Mechanism of action

Mistletoe lectin A-chain (ML-A) acts as an RNA N-glycosidase that specifically depurinates the A4324 residue of the 28S ribosomal RNA within the sarcin/ricin loop. This modification prevents the binding of elongation factors, thereby irreversibly inhibiting protein synthesis and triggering apoptosis through the ribotoxic stress response (Endo et al., 1988; Stirpe, 2004).

03

Biological functions

ApoptosisOther
04

Disease associations

CancerInfection
05

Safety considerations

Systemic toxicityImmunogenicityAnaphylaxisInjection site reactionsHepatotoxicity
06

Interacting drugs

Mistletoe lectin I

6 more in the full profile.

07

Biomarkers

Inhibition of protein synthesisCaspase-3 activationCytokine induction (IL-6, TNF-alpha)

Beyond the preview

Go deeper on 28S ribosomal RNA (28S rRNA) (28S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 28S ribosomal RNA (28S rRNA) (28S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call